please stop broken record, page-9

Mattkid gave you a TU to no avail

Regarding delaying CE mark for two months - limited sales of VitroGrow have been projected in the first six months (due to European summer and no reimbursement approval). As such it is good financial management to extend the expiry date of VitroGrow to a period when it is likely to be sold.

Regarding share price - it has been in a downward channel for ~12 months.

I feel management communication can be criticized however generally not what they are doing. GLTA